Droz, Brian A.
Eli Lilly (United States)
4 papers on CoChatORCID 0009-0002-7118-2326
Most cited papers
- Verified
GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice
Samms, R. J., Christe, M. E., Collins, K. A. L., Pirro, V., Droz, B. A., Holland, A. K., Friedrich, J. L., Wojnicki, S., Konkol, D. L., Cosgrove, R., et al. (2021) · Journal of Clinical Investigation
Diabetes Treatment and ManagementAdipokines, Inflammation, and Metabolic Diseases
Cited by 256
- Verified
Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist
Kawai, T., Sun, B., Yoshino, H., Feng, D., Suzuki, Y., Fukazawa, M., Nagao, S., Wainscott, D. B., Showalter, A. D., Droz, B. A., et al. (2020) · Proceedings of the National Academy of Sciences
Receptor Mechanisms and SignalingDiabetes Treatment and Management
Cited by 231
- Verified
Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue
Samms, R. J., Zhang, G., He, W., Ilkayeva, O., Droz, B. A., Bauer, S. M., Stutsman, C., Pirro, V., Collins, K. A., Furber, E. C., et al. (2022) · Molecular Metabolism
Adipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases
Cited by 93
- Verified
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
Sloop, K. W., Cox, A. L., Wainscott, D. B., White, A., Droz, B. A., Stutsman, C., Showalter, A. D., Suter, T. M., Dunbar, J. D., Snider, B. M., et al. (2024) · Science Translational Medicine
Diabetes Treatment and ManagementReceptor Mechanisms and Signaling
Cited by 52
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free